Ajanta Pharma Launches World's 1st FDC Met XL AMT for Patients with Uncontrolled Hypertension and Cardiovascular Co-morbidity in India MD Brand Connect8 Aug 2023 11:53 AM ISTAjanta Pharma, one of the leaders in the cardiology segment has announced the launch of Met XL AMT, a novel triple drug combination for the...
Submit Justification: CDSCO Tells Akum Pharma on Azelnidipine, Metoprolol FDC drug Dr. Divya Colin26 Jun 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Akum...
Ajanta Pharma gets CDSCO Panel Nod to manufacture, market high blood pressure FDC drug Dr. Divya Colin28 May 2023 5:45 PM ISTNew Delhi: Ajanta Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To Metoprolol, Nebivolol, Olmesartan, Sulfasalazine Susmita Roy9 April 2023 5:52 PM ISTNew Delhi: In line with the preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database, the...
Eris Lifescience gets CDSCO panel nod to study FDC of Metoprolol Succinate, Dapagliflozin Dr. Divya Colin21 Jan 2023 4:30 PM ISTNew Delhi: Directing to present bioequivalence (BE) study results in the Subject Expert Committee (SEC) before initiating the Phase III clinical...
Pure & Cure Healthcare secures CDSCO Panel nod for Phase 4 CT of Ivabradine,Metoprolol Tartrate FDC Dr. Divya Colin1 Jan 2023 5:00 PM ISTNew Delhi: Pure & Cure has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Metoprolol or diltiazem, which is better for rate control in atrial fibrillation? Dr Kartikeya Kohli9 Nov 2022 12:00 PM ISTUSA: A study published in Annals of Pharmacotherapy comparing two drug classes for controlling ventricular rate in patients with atrial fibrillation...
Metoprolol use among COPD patients linked to severe exacerbation of disease Dr. Kamal Kant Kohli19 Oct 2022 8:00 PM ISTU.S.A.: Metoprolol was linked to a greater risk of severe exacerbation, according to the BLOCK COPD study (β -Blockers for the Prevention of Acute...
Physician's opinion on Metoprolol in CVD: The master of all trades! dr. Abhimanyu Uppal11 Feb 2022 11:45 AM ISTIt will not be an overstatement that cardioselective beta-blocker metoprolol has been one of the most researched and at the same time most widely used...
Metoprolol Benefits Patients With Hypertrophic Obstructive Cardiomyopathy - TEMPO Trial MD Bureau29 Dec 2021 9:15 AM ISTThe complexity of hypertrophic cardiomyopathy (HCM) molecular pathophysiology and the efficacy of septal reduction therapies were combined to slow the...
Metoprolol reduces LVOT obstruction in obstructive hypertrophic cardiomyopathy: JACC Medha Baranwal22 Dec 2021 9:00 AM ISTDenmark: Treatment with metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) significantly reduced left ventricular...
IV diltiazem tops metoprolol for treating patients of atrial fibrillation with rapid ventricular rate: Study Medha Baranwal15 Dec 2021 10:45 AM ISTChina: Intravenous diltiazem and metoprolol are used commonly for treating atrial fibrillation (AF) with rapid ventricular rate (RVR) in the emergency...
